Purchases and Sales Made in Q3 2024 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q3 2024. The information is specifically focused on institutions that hold shares of EyePoint Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2024
Q3 2024
|
Dynamic Technology Lab Private LTD
Singapore, U0 |
SELL
|
- |
-41.1K- 77.35% |
$312K - $434K
|
12K
$119K
|
|
Nov 14, 2024
Q3 2024
|
State Of Wisconsin Investment Board
Madison, WI |
SELL
|
- |
-43.5K- 31.19% |
$330K - $459K
|
96K
$947K
|
|
Nov 14, 2024
Q3 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-49.1K- 42.28% |
$372K - $518K
|
67.1K
$661K
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-55.8K- 74.1% |
$423K - $588K
|
19.5K
$192K
|
|
Oct 03, 2024
Q3 2024
|
Sg Americas Securities, LLC
|
SELL
|
- |
-57K- 74.7% |
$432K - $601K
|
19.3K
$190K
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-59.2K- 58.16% |
$449K - $624K
|
42.6K
$420K
|
|
Nov 08, 2024
Q3 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-71.8K- 59.54% |
$544K - $757K
|
48.8K
$481K
|
|
Nov 14, 2024
Q3 2024
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-102KClosed |
$776K - $1.08M
|
0
$0
|
|
Nov 12, 2024
Q3 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-126K- 74.35% |
$954K - $1.33M
|
43.4K
$428K
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-143K- 23.88% |
$1.09M - $1.51M
|
457K
$4.51M
|
|
Nov 14, 2024
Q3 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-179K- 28.45% |
$1.36M - $1.89M
|
451K
$4.45M
|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-182K- 96.54% |
$1.38M - $1.92M
|
6.51K
$64.2K
|
|
Nov 14, 2024
Q3 2024
|
Oracle Investment Management Inc
Greenwich, CT |
SELL
|
- |
-199K- 85.98% |
$1.51M - $2.1M
|
32.5K
$320K
|
|
Nov 07, 2024
Q3 2024
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
SELL
|
- |
-211K- 74.71% |
$1.6M - $2.23M
|
71.5K
$705K
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-214K- 79.13% |
$1.62M - $2.25M
|
56.3K
$555K
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-437K- 19.38% |
$3.31M - $4.6M
|
1.82M
$17.9M
|
|
May 14, 2025
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-437K- 19.38% |
$3.31M - $4.6M
|
1.82M
$17.9M
|
|
Nov 14, 2024
Q3 2024
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-444K- 93.29% |
$3.37M - $4.68M
|
32K
$315K
|
|
Nov 14, 2024
Q3 2024
|
Laurion Capital Management LP
New York, NY |
SELL
|
- |
-613K- 57.11% |
$4.64M - $6.46M
|
460K
$4.54M
|
|
Nov 14, 2024
Q3 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-803K- 38.75% |
$6.09M - $8.46M
|
1.27M
$12.5M
|
|
Nov 14, 2024
Q3 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-897K- 97.3% |
$6.8M - $9.45M
|
24.9K
$245K
|